ENTRECTINIB - Food and Drug Administration
- Set ID
- e6575cfe-b3b7-4da4-be93-fa17ff8a6d0a
- Type
- Indexing - product concept
- Effective date
- 2025-07-21
- Version
- 2
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use ROZLYTREK ® safely and effectively. See full prescribing information for ROZLYTREK. ROZLYTREK ® (entrectinib) capsules, for oral use ROZLYTREK ® (entrectinib) oral pellets Initial U.S. Approval: 2019 | Product name | Genentech, Inc. | F. Hoffmann-La Roche AG | 2025-12-04 |